The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV is a Federal Supply Schedule (FSS) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Cameron Pharmaceuticals, LLC. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The contract has a ceiling value of $368,460.00 and a period of performance from June 1, 2024 to May 31, 2029. The contract is a multiple award FSS with no set-aside. As an FSS contract, it...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at a ceiling of $250,000.00, was awarded to TWI Pharmaceuticals USA, Inc. on February 1, 2023 with a period of performance through January 31, 2028. The contract is for FSS 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS," indicating that the scope includes the...
The federal contract IDV represents a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Amerisource Health Services, LLC. The contract, valued at up to $750,000.00, is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSC 65 I B) for the Veterans Integrated Service Network 12 region. The contract is a multiple-award FSS with a period of performance running from September 15, 2023 to September 14, 2028. As an FSS contract,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract has a ceiling value of $419,690.00 and a period of performance ending on September 1, 2027. The prime contractor is Altathera Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The purpose of this FSS contract is to provide the VA VISN 12 with "Drugs,...
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Therapeuticsmd, Inc. for the provision of pharmaceuticals, drugs, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. This multiple-award contract has a potential value of $250,000.00 and a period of performance from May 15, 2020 to May 15, 2024. Therapeuticsmd, Inc.,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 12. The prime contractor is Alpha Cognition USA, Inc., a for-profit manufacturer. The contract has a ceiling value of $25,000.00 and a period of performance through September 30, 2025. It is a multiple award IDV, meaning...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to acquire pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. Circassia Inc. was awarded the IDV with a potential value of $30.4 million and a period of performance through March 2025. The IDV facilitates the acquisition of drugs, pharmaceuticals, and hematology-related products through task orders or delivery orders issued...
The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS) contract under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products, awarded by the Department of Veterans Affairs to Vantive US Healthcare LLC. The contract has a ceiling value of $25,000 and a period of performance through February 1, 2025. The purpose of this IDV is to establish pre-competed procurement mechanisms that allow rapid acquisition of medical supplies and pharmaceuticals for the...